Over the last few decades, China's cosmetic surgery sector has transformed into one of the world's largest and fastest-growing industries. The origins of cosmetic surgery in China can be traced back to ancient techniques of body modification, although modern cosmetic surgery gained popularity in the late twentieth century. The construction of specialised clinics and hospitals began, with an emphasis on facial surgeries such as double eyelid surgery and rhinoplasty. Botox injections, fillers, and laser treatments were popular in the 2010s, particularly among younger consumers. This trend was followed by an increase in the usage of digital marketing and social media, with platforms such as WeChat and Weibo playing important roles in advertising cosmetic treatments and sharing patient experiences. In 2009, the Ministry of Health introduced new laws to improve cosmetic surgery safety by requiring practitioners to be licensed and certified. This approach aims to reduce the number of unqualified practitioners and increase patient safety. Subsequent regulations, issued in 2014 and 2017, increased clinic compliance standards by requiring all medical devices and materials used in cosmetic operations to be registered with the government. The COVID-19 pandemic had a significant impact on the cosmetic surgery sector in China. Initially, in early 2020, many elective treatments were postponed, resulting in a significant decrease in surgeries. However, as limits were lifted later in the year, the industry began to recover, fuelled by pent-up demand for cosmetic treatments. The pandemic encouraged a shift towards virtual consultations and online marketing, allowing clinics to continue engaging with potential patients. Furthermore, the experience of lockdowns prompted many people to focus on self-improvement, raising interest in both surgery and non-surgical modifications. According to the research report "China Cosmetic Surgery Market Overview, 2029," published by Bonafide Research, the China's cosmetic surgery market is anticipated to grow at more than 9.08% CAGR from 2024 to 2029. Beijing Aier Intech Medical Cosmetology Hospital, Shanghai Changzheng Hospital, and Guangzhou Panyu Aohua Hospital are among the leading domestic players in the Chinese cosmetic surgery business. These institutions are well-known for their cutting-edge technology and highly skilled experts, and they provide a wide range of services, including invasive operations and non-invasive therapies. Furthermore, local brands like as Yestar Medical and Hunan Yihua Medical Technology have arisen, with the goal of delivering affordable and accessible cosmetic solutions. Promotions in the Chinese cosmetic surgery business have become more sophisticated, utilising social media influencers and online channels to reach younger demographics. Many clinics offer package packages and seasonal discounts to entice customers, making operations more affordable. The rise of "beauty tourism" has also contributed to market expansion, since many Chinese customers travel to prominent cosmetic surgery locations such as South Korea and Thailand, thereby fuelling the business. The market is expected to develop further because to ongoing improvements in surgical techniques and non-invasive procedures, as well as stringent regulations and a growing consumer base. As the market matures, the intersection of cultural influences, legislative frameworks, and technical breakthroughs will shape the future of cosmetic surgery in China.
Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally
Download SampleInvasive operations, such as rhinoplasty, breast augmentation, liposuction, and facelifts, usually require considerable interventions and extended recovery times. These treatments are popular among people looking for drastic alterations in their looks, particularly ladies aged 20 to 40. The influence of media beauty standards, as well as the need for social approval, fuel demand for these operations, adding to their widespread use. In contrast, non-invasive techniques have grown in favour in recent years. Botox injections, dermal fillers, chemical peels, and laser treatments are among the available options. Non-invasive solutions are popular among younger consumers due to their ease, minimum downtime, and lower risk profiles. With the rise of social media and beauty gurus, more people, particularly those aged 18 to 29, are interested in exploring these quick and less daunting ways to improve their appearance. Reputable hospitals and clinics like as Beijing Aier Intech Medical Cosmetology Hospital, Shanghai Changzheng Hospital, and Guangzhou Panyu Aohua Hospital are among the Chinese cosmetic surgery market's key domestic players. These institutions are well-known for their cutting-edge technology, talented practitioners, and high-quality care. Non-invasive methods now dominate the market in China, owing to their ease of use and the growing trend of self-care among younger consumers. The increasing use of social media platforms has also helped to normalise these therapies, making them more attractive and acceptable. Both men and women are active participants in China's cosmetic surgery sector, but women continue to dominate. Cosmetic operations have traditionally been more popular among women due to cultural beauty ideals that value youth, smooth skin, and facial symmetry. Women commonly have blepharoplasty (double eyelid surgery), rhinoplasty (nose reshaping), breast augmentation, and liposuction. Women, particularly those aged 20 to 40, are motivated by cultural standards that place a high value on physical appearance. Many people want cosmetic operations not only for aesthetic reasons, but also to boost their confidence and job chances, especially in highly competitive urban areas. However, the male category is expanding significantly, driven by shifting attitudes about personal maintenance and appearance. Men, particularly in urban settings, are increasingly using cosmetic modifications as part of their overall self-care routines. Rhinoplasty, gynaecomastia surgery (to decrease extra breast tissue), and non-invasive treatments such as Botox and skin rejuvenation are all popular among males. The advent of male influencers and celebrities who freely publicise their cosmetic procedures has helped to eliminate the stigma associated with male cosmetic surgery in China. Domestic vendors and distributors play an important role in meeting the increased demand from both genders. Leading aesthetic device and material providers, including Huaxi Aesthetic Medical and Yestar Medical, ensure that clinics and hospitals have access to cutting-edge technologies and products for both invasive and non-invasive procedures. Despite increased interest among men, women continue to dominate China's cosmetic surgery business. In the Chinese cosmetic surgery market, different age groups have varied preferences and trends. The 30-54 age group dominates the market, as they prefer more complex and invasive procedures to keep or regain their young appearance. Financial stability also helps this population afford more expensive operations. The 13-29 age range is quickly expanding in the cosmetic surgery industry, with many choosing non-invasive treatments including Botox, dermal fillers, and laser treatments. This younger age is heavily influenced by social media, beauty gurus, and evolving societal beauty expectations, which has led them to seek cosmetic modifications earlier in life. Procedures like double eyelid surgery (blepharoplasty) and nose contouring (rhinoplasty) are very common among this age range. Social media platforms such as WeChat, Douyin (TikTok), and Xiaohongshu (Little Red Book) have had a significant impact on the 13-29 age group, normalising the use of cosmetic operations. The market category for people over the age of 55 is smaller. While older people are becoming increasingly interested in cosmetic surgery, they are less likely to undergo invasive treatments due to health concerns and lengthier recovery times. Domestic vendors and distributors, such as Yestar Medical and Huaxi Aesthetic Medical, offer critical products and technology customised to the demands of these different age groups. The 30-54 age group dominates the Chinese cosmetic surgery market, owing to their financial ability to pay more complex procedures and their desire to preserve a younger appearance.
Considered in this report • Historic year: 2018 • Base year: 2023 • Estimated year: 2024 • Forecast year: 2029 Aspects covered in this report • Cosmetic Surgery market Outlook with its value and forecast along with its segments • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation By Procedure Type • Invasive Procedures (Breast augmentation, Liposuction, Nose reshaping, Eyelid Surgery, Tummy tuck and Others) • Non-invasive Procedures (Botox injections, Soft tissue fillers, Chemical peel, Laser hair removal, Microdermabrasion and Others)
By Gender • Female • Male By Age Group • 30-54 • 13-29 • 55 and above The approach of the report: This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources. Intended audience This report can be useful to industry consultants, manufacturers, suppliers, associations, and organizations related to the Cosmetic Surgery industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.
We are friendly and approachable, give us a call.